Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-02-11

Clinical Trial Update: The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating isocapnic hyperventilation for methanol poisoning was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oslo University Hospital | Conditions: Methanol Poisoning | Phase 1 | Status: WITHDRAWN